Axolotl Biosciences provides turn-key reagents such as functional bioinks, 3D tissue models, and consulting services in the field of 3D bioprinting. Our goal is to improve human health through novel 3D printing technologies. We incorporated in March 2020. Our initial product is a highly optimized bioink formulation for 3D printing neural tissues using stem cells. Our novel neurobioink is capable of printing delicate stem cells while maintaining a high-level cell viability and function. We anticipate expanding our neurobioink product line to include specialized inks for printing different types of neural tissue using our patent pending bioink formulations and expanding to other tissues as we continue to optimize our formulations for multiple bioprinting platforms. We will also license our novel 3D tissues as well as providing consulting services for organizations wanting to 3D print tissues.